Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


22.01.2024

1 AIDS
6 BMJ
1 Clin Microbiol Rev
1 J Infect Dis
1 JAMA
2 Lancet
1 Nat Immunol
2 Pediatr Infect Dis J
1 Pediatrics
6 PLoS One
1 Proc Natl Acad Sci U S A
13 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. DUNCAN MC, Omondi FH, Kinloch NN, Lapointe HR, et al
    Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size.
    AIDS. 2024 Jan 15. doi: 10.1097/QAD.0000000000003841.
    PubMed         Abstract available


    BMJ

  2. IACOBUCCI G
    Covid-19: Vaccines have saved at least 1.4 million lives in Europe, WHO reports.
    BMJ. 2024;384:q125.
    PubMed        

  3. LARSON HJ, Lin L
    Generative artificial intelligence can have a role in combating vaccine hesitancy.
    BMJ. 2024;384:q69.
    PubMed         Abstract available

  4. RUGGERI K, Vanderslott S, Yamada Y, Argyris YA, et al
    Behavioural interventions to reduce vaccine hesitancy driven by misinformation on social media.
    BMJ. 2024;384:e076542.
    PubMed        

  5. ASTUTI SI, Sufehmi H, Wilhelm E
    Centring health workers and communities is key to building vaccine confidence online.
    BMJ. 2024;384:q82.
    PubMed        

  6. IACOBUCCI G
    Measles: Warning given over low MMR uptake after cases rise to 200 in West Midlands.
    BMJ. 2024;384:q113.
    PubMed        

  7. COOPER S, Gadanya MA, Kaawa-Mafigiri D, Katoto PDMC, et al
    Using social media to build confidence in vaccines: lessons from community engagement and social science research in Africa.
    BMJ. 2024;384:e075564.
    PubMed         Abstract available


    Clin Microbiol Rev

  8. WILLIAMS E, Seib KL, Fairley CK, Pollock GL, et al
    Neisseria gonorrhoeae vaccines: a contemporary overview.
    Clin Microbiol Rev. 2024 Jan 16:e0009423. doi: 10.1128/cmr.00094.
    PubMed         Abstract available


    J Infect Dis

  9. GRANT LR, Begier E, Theilacker C, Barry R, et al
    Multicountry review of Streptococcus pneumoniae serotype distribution among adults with community-acquired pneumonia.
    J Infect Dis. 2023 Sep 4:jiad379. doi: 10.1093.
    PubMed         Abstract available


    JAMA

  10. HARRIS E
    CDC Warns of Low Vaccination Rates Amid Spike in Respiratory Diseases.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27428.
    PubMed        


    Lancet

  11. ALVES L
    Brazil to start widespread dengue vaccinations.
    Lancet. 2024;403:133.
    PubMed        

  12. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    PubMed        


    Nat Immunol


  13. Building a next-generation, two-component protein subunit vaccine against monkeypox virus.
    Nat Immunol. 2024 Jan 18. doi: 10.1038/s41590-023-01735.
    PubMed        


    Pediatr Infect Dis J

  14. BLANCHARD-ROHNER G, Sanchez C, Andre MC, Bressieux-Degueldre S, et al
    COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children.
    Pediatr Infect Dis J. 2024 Jan 15. doi: 10.1097/INF.0000000000004206.
    PubMed         Abstract available

  15. BRESSLER SS, Bruden D, Hammitt LL, Chukwuma U, et al
    Trends in Otitis Media Ambulatory Visits in American Indian and Alaska Native Children During the Pneumococcal Conjugate Vaccine Period and the COVID-19 Pandemic.
    Pediatr Infect Dis J. 2024 Jan 15. doi: 10.1097/INF.0000000000004207.
    PubMed         Abstract available


    Pediatrics

  16. RAZZAGHI H, Forrest CB, Hirabayashi K, Wu Q, et al
    Vaccine Effectiveness Against Long COVID in Children.
    Pediatrics. 2024 Jan 16. doi: 10.1542/peds.2023-064446.
    PubMed         Abstract available


    PLoS One

  17. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    PubMed         Abstract available

  18. VENKATESAN MM, Barnoy S, Frenck R, McNeal M, et al
    B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3.
    PLoS One. 2024;19:e0290987.
    PubMed         Abstract available

  19. HOBBS A, Aldosery A, Kostkova P
    Low credibility URL sharing on Twitter during reporting linking rare blood clots with the Oxford/AstraZeneca COVID-19 vaccine.
    PLoS One. 2024;19:e0296444.
    PubMed         Abstract available

  20. MORCIANO C, Spila Alegiani S, Menniti Ippolito F, Belleudi V, et al
    Post-marketing active surveillance of Guillain Barre Syndrome following COVID-19 vaccination in persons aged >/=12 years in Italy: A multi-database self-controlled case series study.
    PLoS One. 2024;19:e0290879.
    PubMed         Abstract available

  21. SAAKA SA, Mohammed K, K A Pienaah C, Luginaah I, et al
    Child malaria vaccine uptake in Ghana: Factors influencing parents' willingness to allow vaccination of their children under five (5) years.
    PLoS One. 2024;19:e0296934.
    PubMed         Abstract available

  22. AIMAN S, Farooq QUA, Han Z, Aslam M, et al
    Core-genome-mediated promising alternative drug and multi-epitope vaccine targets prioritization against infectious Clostridium difficile.
    PLoS One. 2024;19:e0293731.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  23. MA F, Xu Q, Wang A, Yang D, et al
    A universal design of restructured dimer antigens: Development of a superior vaccine against the paramyxovirus in transgenic rice.
    Proc Natl Acad Sci U S A. 2024;121:e2305745121.
    PubMed         Abstract available


    Vaccine

  24. MCADAM E, Hayashi K, Barker B, Reddon H, et al
    COVID-19 vaccination among young people who use drugs in Vancouver, Canada.
    Vaccine. 2024 Jan 14:S0264-410X(24)00009-4. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  25. BEARSON SMD, Monson MS, Bearson BL, Whelan SJ, et al
    Commercial vaccine provides cross-protection by reducing colonization of Salmonella enterica serovars Infantis and Hadar in turkeys.
    Vaccine. 2024 Jan 13:S0264-410X(23)01500-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  26. GUO W, Wang C, Song X, Xu H, et al
    Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus.
    Vaccine. 2024 Jan 13:S0264-410X(24)00020-3. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  27. NAUTA J
    Estimand for non-inferiority influenza vaccine immunogenicity trials.
    Vaccine. 2024 Jan 13:S0264-410X(24)00014-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  28. THOMPSON KM, Kalkowska DA, Kidd SE, Burns CC, et al
    Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.
    Vaccine. 2024 Jan 12:S0264-410X(23)01541-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  29. KANG DW, Kim CR, Song JY, Park SK, et al
    Cost-effectiveness of the 20-valent pneumococcal conjugate vaccine versus the 23-valent pneumococcal polysaccharide vaccine for older adults in South Korea.
    Vaccine. 2024 Jan 14:S0264-410X(24)00031-8. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  30. KING ML
    How manufacturing won or lost the COVID-19 vaccine race.
    Vaccine. 2024 Jan 15:S0264-410X(23)01477-9. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  31. TIAN X, Wang J, Chen H, Ding M, et al
    In vivo functional immunoprotection correlates for vaccines against invasive bacteria.
    Vaccine. 2024 Jan 16:S0264-410X(24)00018-5. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  32. HARALAMBIEVA IH, Monroe JM, Ovsyannikova IG, Warner ND, et al
    Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine.
    Vaccine. 2024 Jan 16:S0264-410X(24)00032-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  33. FAN J, Song Y, Cong S, Millman AJ, et al
    Assessing interventions to encourage primary care health workers to recommend influenza vaccination and the impact on vaccination uptake for persons with Non-Communicable diseases in China.
    Vaccine. 2024 Jan 16:S0264-410X(24)00011-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  34. LEMMER Y, Chapman R, Abolnik C, Smith T, et al
    Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in golden Syrian hamsters.
    Vaccine. 2024 Jan 17:S0264-410X(24)00036-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available

  35. FIEBELKORN AP, Adelsberg S, Anthony R, Ashenafi S, et al
    The role of funded partnerships in working towards decreasing COVID-19 vaccination disparities, United States, March 2021-December 2022.
    Vaccine. 2024 Jan 17:S0264-410X(23)01507-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  36. MEMEDOVICH A, Orr T, Hollis A, Salmon C, et al
    Social network risk factors and COVID-19 vaccination: A cross-sectional survey study.
    Vaccine. 2024 Jan 18:S0264-410X(24)00005-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.